Close to 130 industry and non-industry players, across the globe, claim to have the necessary expert

The production of radiopharmaceuticals as compared to traditional pharmaceuticals is a multifaceted procedure and requires specialized facilities, equipment and operational expertise. Further, owing to its inherent hazardous nature, radiopharmaceuticals have a complex regulatory market authorization process. Consequently, a number of innovator companies have demonstrated a preference for outsourcing radiopharmaceutical manufacturing to contract service providers.

 

To order this 320+ page report, which features 45+ figures and 100+ tables, please visit this - https://www.rootsanalysis.com/reports/nuclear-medicine-and-radiopharmaceuitcals-manufacturing.html

 

The USD 6+ billion (by 2030) financial opportunity associated with nuclear medicine and radiopharmaceuticals manufacturing, has been analyzed across the following segments:

Target Disease Indication

Breast CancerChronic Lymphocytic LeukemiaColorectal CancerHead and Neck CancerLung CancerLupus NephritisMelanomaMultiple MyelomaPrimary Sjögren's SyndromeOthers

Target Immune Checkpoint

B7-H3CD38CD40CD47Others

Mechanism of Action

InhibitoryStimulatory

Therapeutic Modality

Monoclonal AntibodySmall Molecule

Type of Therapy

MonotherapyCombination Therapy

Route of Administration

IntravenousSubcutaneousOthers

Key Geographical Regions

North AmericaEuropeAsia-Pacific and the Rest of the World

 

The Nuclear Medicine and Radiopharmaceuticals Manufacturing Market, 2020-2030” report features the following companies, which we identified to be key players in this domain: 

Advanced Accelerator ApplicationsBelgian Nuclear Research Center (SCK•CEN)Cardinal HealthChina Isotope & Radiation CorporationCurium PharmaDuChemBioEckert & ZieglerEczacibasi-MonrolGE HealthcareJubilant DraxImageLantheus Medical ImagingNihon Medi-PhysicsNordionPETNET SolutionsSinoTau PharmaceuticalsSOFIE

 

Table of Contents

 

1. Preface

2. Executive Summary

3. Introduction

4. Nuclear Medicine and Radiopharmaceuticals Manufacturers (Industry Players): Current Market Landscape

5. Nuclear Medicine and Radiopharmaceuticals Manufacturers (Non-Industry Players): Current Market Landscape

6. Nuclear Medicine and Radiopharmaceuticals Manufacturers in North America

7. Nuclear Medicine and Radiopharmaceuticals Manufacturers in Europe

8. Nuclear Medicine and Radiopharmaceuticals Manufacturers in Asia-Pacific And Rest of The World

9. Nuclear Medicine and Radiopharmaceuticals Manufacturers: Company Competitiveness Analysis

10. Partnerships and Collaborations

11. Production and Supply Chain of Medical Isotope Molybdenum-99 (Technetium-99m)

12. Market Forecast and Opportunity Analysis

13. Concluding Remarks

14. Executive Insights

15. Appendix 1: Tabulated Data

16. Appendix 2: List of Companies and Organizations

 

To purchase a copy, please visit https://www.rootsanalysis.com/reports/nuclear-medicine-and-radiopharmaceuitcals-manufacturing.html

 

Contact Details

Gaurav Chaudhary

+1 (415) 800 3415

[email protected]